Jongphil Kim

About

Jongphil Kim is a Professor at Moffitt Cancer Center in the United States. His research primarily focuses on hematopoietic cell transplantation, graft-versus-host disease, and methodologies for improving patient outcomes in various cancers. Recent publications include studies on the efficacy of Letermovir in cytomegalovirus management and the impact of melphalan dosing on gastrointestinal toxicity in allogeneic transplantation. Additionally, he has contributed to investigations on risk prediction in penile cancer and the relationship between genetic factors and treatment responses in allogeneic HSCT patients.